The pitfalls of growing nanomaterials

References

• 1 Mulleneisen NK. The new GOLD standard recommendation is not implemented in everyday life. Pneumologie 67(4), 241–242 (2013).
  Medline CASGoogle Scholar
• 2 Blaustein AR, Dobson A. Extinctions: a message from the frogs. Nature 439(7073), 143–144 (2006).
  Medline CASGoogle Scholar
• 3 Maynard AD, Aitken RJ, Butz T et al. Safe handling of nanotechnology. Nature 444(7117), 267–269 (2006).
  Medline CASGoogle Scholar
• 4 Roberts J, Bagci E, Zawawi MA et al. Using quantum confinement to uniquely identify devices. Sci. Rep. 5, 16456 (2015).
  Medline CASGoogle Scholar
• 5 Lai CY, Santos S, Chiesa M. Reconstruction of height of sub-nanometer steps with bimodal atomic force microscopy. Nanotechnology 27(7), 075701 (2016).
  MedlineGoogle Scholar
• 6 Walt DR. Chemistry. Miniature analytical methods for medical diagnostics. Science 308(5719), 217–219 (2005).
  Medline CASGoogle Scholar
• 7 Wright J. Deliver on a promise. Sci. Am. 311(1), S12–S13 (2014).
  MedlineGoogle Scholar
• 8 Miller MA, Gadde S, Pfirschke C et al. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci. Transl. Med. 7(314), 314ra183 (2015).
  MedlineGoogle Scholar
• 9 Aires A, Ocampo SM, Simoes BM et al. Multifunctionalized iron oxide nanoparticles for selective drug delivery to CD44-positive cancer cells. Nanotechnology 27(6), 065103 (2016).
  MedlineGoogle Scholar
• 10 Rolle AM, Hasenberg M, Thornton CR et al. ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo. Proc. Natl Acad. Sci. USA 113(8), E1026–E1033 (2016).
  Medline CASGoogle Scholar
• 11 Shi D, Xu X, Ye Y et al. Photo-cross-linked scaffold with kartogenin-encapsulated nanoparticles for cartilage regeneration. ACS Nano. 10(1), 1292–1299 (2016).
  Medline CASGoogle Scholar
• 12 Service RF. Nanotechnology. Calls rise for more research on toxicology of nanomaterials. Science 310(5754), 1609 (2005).
  Medline CASGoogle Scholar
• 13 Zhang YN, Poon W, Tavares AJ et al. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination. J. Control. Release doi:10.1016/j.jconrel.2016.01.020 (2016) (Epub ahead of print).
  Google Scholar
• 14 Gibbs JB. Mechanism-based target identification and drug discovery in cancer research. Science 287(5460), 1969–1973 (2000).
  Medline CASGoogle Scholar
• 15 Shiekh FA. Synthetic nanocarriers as a new paradigm. Nanomedicine (Lond.) 9(15), 2259–2262 (2014).
  CASGoogle Scholar
• 16 Shiekh FA, Mian SH, Arja SB et al. Targeted combination nanotherapeutics in cancer a real promise. Nanomedicine (Lond.) 10(12), 1855–1857 (2015).
  CASGoogle Scholar
• 17 Tietjen GT, Saltzman WM. Nanomedicine gets personal. Sci. Transl. Med. 7(314), 314fs47 (2015).
  MedlineGoogle Scholar
• 18 Bourzac K. Nanotechnology: carrying drugs. Nature 491(7425), S58–S60 (2012).
  MedlineGoogle Scholar
• 19 Pearce JM. Make nanotechnology research open-source. Nature 491, 519–521 (2012).
  Medline CASGoogle Scholar
• 20 Dresselhaus MS. A revolution of nanoscale dimensions. Nat. Rev. Mater. 1, 15017 (2016).
  CASGoogle Scholar
• 21 Shiekh FA. Highlights from recent advances in nanomedicine. Nanomedicine (Lond.) 9(9), 1287–1289 (2014).
  CASGoogle Scholar
• 22 Sengupta S, Sasisekharan R. Exploiting nanotechnology to target cancer. Br. J. Cancer 96(9), 1315–1319 (2007).
  Medline CASGoogle Scholar
• 23 Trpkovic A, Todorovic-Markovic B, Trajkovic V. Toxicity of pristine versus functionalized fullerenes: mechanisms of cell damage and the role of oxidative stress. Arch. Toxicol. 86(12), 1809–1827 (2012).
  Medline CASGoogle Scholar
• 24 Smith C. Tools for drug discovery: tools of the trade. Nature 446(7132), 219–222 (2007).
  Medline CASGoogle Scholar
• 25 Yang CH, Wang LS, Chen SY et al. Microfluidic assisted synthesis of silver nanoparticle-chitosan composite microparticles for antibacterial applications. Int. J. Pharm. doi:10.1016/j.ijpharm.2016.01.010 (2016) (Epub ahead of pub).
  Google Scholar
• 26 Service RF. Materials and biology. Nanotechnology takes aim at cancer. Science 310(5751), 1132–1134 (2005).
  MedlineGoogle Scholar
• 27 Pinheiro AV, Han D, Shih WM et al. Challenges and opportunities for structural DNA nanotechnology. Nat. Nanotechnol. 6(12), 763–772 (2011).
  Medline CASGoogle Scholar
• 28 Dong Y, Love KT, Dorkin JR et al. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates. Proc. Natl Acad. Sci. USA 111(11), 3955–3960 (2014).
  Medline CASGoogle Scholar
• 29 Pu K, Chattopadhyay N, Rao J. Recent advances of semiconducting polymer nanoparticles in In vivo molecular imaging. J. Control. Release doi:10.1016/j.jconrel.2016.01.004 (2016) (Epub ahead of print).
  MedlineGoogle Scholar
• 30 Samuel RE. Nano rules fall foul of data gap. Nature 480(7376), 160–161 (2011).
  MedlineGoogle Scholar
• 31 Riego-Sintes J. Regulation: safety-test initiatives for nanomaterials. Nature 482(7383), 35 (2012).
  Medline CASGoogle Scholar
• 32 Muhlebach S, Borchard G, Yildiz S. Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars. Nanomedicine (Lond.) 10(4), 659–674 (2015).
  Google Scholar